Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
101M
-
Number of holders
-
200
-
Total 13F shares, excl. options
-
60.1M
-
Shares change
-
-505K
-
Total reported value, excl. options
-
$2.22B
-
Value change
-
-$20.1M
-
Put/Call ratio
-
0.51
-
Number of buys
-
92
-
Number of sells
-
-83
-
Price
-
$36.98
Significant Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) as of Q3 2019
234 filings reported holding FGEN - FIBROGEN INC - Common Stock, $0.01 par value as of Q3 2019.
FIBROGEN INC - Common Stock, $0.01 par value (FGEN) has 200 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 60.1M shares
of 101M outstanding shares and own 59.54% of the company stock.
Largest 10 shareholders include FMR LLC (8.73M shares), VANGUARD GROUP INC (7.29M shares), BlackRock Inc. (6.58M shares), HILLHOUSE CAPITAL ADVISORS, LTD. (3.5M shares), STATE STREET CORP (2.85M shares), JANUS HENDERSON GROUP PLC (2.67M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.49M shares), JPMORGAN CHASE & CO (1.79M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.5M shares), and FIRST TRUST ADVISORS LP (1.31M shares).
This table shows the top 200 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.